Clinical Trial Update: COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the combination of colchicine and non-enteric coated aspirin for cardiovascular outcomes in patients with type 2 diabetes is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Aspirin (non-enteric coated) (acetylsalicylic acid)
• COLCHICINE (Colchicine)

Snippet

Sponsor: Montreal Heart Institute | Conditions: Diabete Type 2, Cardiovascular Diseases | Phase 3 | Status: RECRUITING